News Articles on {?keyword?} | ABS-CBN News

Arthritis drug cuts death risk in high-risk patients: study

Nancy Lapid, Reuters
Posted at Sep 12 12:20 PM

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Read more »

Clot risk far lower from vaccines than virus: UK study

Agence France-Presse
Posted at Aug 27 07:26 PM

The risk of rare blood clotting after receiving Covid-19 jabs is far lower than from the virus, a study found out. Read more »

AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd

Pushkala Aripaka, Reuters
Posted at Jul 28 06:55 PM

AstraZeneca's COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on Wednesday, after worries over side-effects. Read more »

AstraZeneca shots should be halted for over-60s - EMA official

Reuters
Posted at Jun 13 10:05 PM

Countries should avoid giving the AstraZeneca coronavirus vaccine to people over 60, an EU official said amid worries over rare blood clotting.   Read more »

US CDC finds more clotting cases after J&J vaccine, sees causal link

Michael Erman and Julie Steenhuysen, Reuters
Posted at May 13 07:06 AM

The US Centers for Disease Control and Prevention said on Wednesday it had found more cases of potentially life-threatening blood clotting among people who received the Johnson & Johnson COVID-19 vaccine and sees a "plausible causal association." Read more »

Philippines OKs use of AstraZeneca COVID-19 vaccine for those below 60

Katrina Domingo, ABS-CBN News
Posted at May 07 03:09 PM

The Department of Health (DOH) on Friday said local governments may resume the use of AstraZeneca vaccines on individuals aged below 60, saying there have been no reports of post-vaccination blood clotting in the Philippines. Read more »

US OKs restart of Johnson & Johnson COVID-19 vaccinations: regulators

Agence France-Presse
Updated as of Apr 24 09:00 AM

US authorities on Friday (Saturday morning Manila time) approved the resumption of COVID-19 vaccinations using Johnson & Johnson's shots following the recommendation of an expert panel.  Read more »

US experts recommend resuming J&J COVID-19 vaccinations

Agence France-Presse
Updated as of Apr 24 07:30 AM

Europe's medicines regulator said Tuesday that blood clots should be listed as a "very rare" side effect of Johnson & Johnson's coronavirus vaccine. Read more »

Guideline to be issued before AstraZeneca COVID-19 vaccine re-use on those under 60 y.o.

Kristine Sabillo, ABS-CBN News
Posted at Apr 19 03:46 PM

The Department of Health will issue a guideline before the use of the AstraZeneca COVID-19 vaccine on people under 60 years old resumes, it said Monday. Read more »

Canada has second case of rare blood clots after AstraZeneca vaccine

Reuters
Posted at Apr 18 09:59 AM

Canada on Saturday reported a second case of rare blood clots with low platelets after immunization with AstraZeneca's COVID-19 vaccine in a week, while it said it still recommended the use of the shot.   Read more »

J&J scientists refute claim that COVID-19 vaccine's design linked to clots

Julie Steenhuysen, Reuters
Posted at Apr 17 07:34 AM

CHICAGO - Scientists at Johnson & Johnson on Friday refuted an assertion in a major medical journal that the design of their COVID-19 vaccine, which is similar AstraZeneca's, may explain why both have been linked to very rare brain blood clots in some vaccine recipients. Read more »

AstraZeneca maaari nang gamitin ng mga 59 anyos pababa: FDA

ABS-CBN News
Posted at Apr 15 08:19 PM

Itutuloy na ang pagtuturok ng mga COVID-19 vaccine ng AstraZeneca sa mga edad 59 anyos pababa, ayon sa FDA.   Read more »

FDA OKs use of AstraZeneca COVID-19 vaccine after check on clotting concerns

Jamaine Punzalan, ABS-CBN News
Updated as of Apr 15 10:55 PM

MANILA (UPDATED) — The Philippines' drug regulator on Thursday recommended the resumption of use of Britain's AstraZeneca COVID-19 vaccine for the country's inoculation program after looking into reports that it had caused very rare blood clots abroad.  Read more »

EXPLAINER: How worried should we be about blood clots linked to 2 COVID-19 vaccines?

John Miller and Ludwig Burger, Reuters
Posted at Apr 14 08:08 PM

ZURICH - US regulators have recommended pausing the use of Johnson and Johnson's COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died. Read more »

Clot questions over AstraZeneca and J&J vaccine

Paul Ricard, Agence France-Presse
Posted at Apr 14 09:14 AM

Here is what we know about the two vaccines, which are based on the same technology.  Read more »

US FDA to scrutinize vaccine design behind COVID shots linked to blood clots

Julie Steenhuysen and Kate Kelland, Reuters
Posted at Apr 14 06:51 AM

In Europe, health regulators said last week there was a possible link between the AstraZeneca Plc vaccine and 169 cases of a rare brain blood clot. Read more »

Australia reports second AstraZeneca blood clot case, vaccine rollout steady

Renju Jose, Reuters
Posted at Apr 13 03:20 PM

Australia said Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise in inoculation cancellations as authorities try to steady a bungled immunization campaign. Read more »

Australia abandons COVID-19 vaccination targets after new advice on AstraZeneca shots

Paulina Duran, Reuters
Posted at Apr 12 08:27 AM

SYDNEY - Australia has abandoned a goal to vaccinate nearly all of its 26 million population by the end of 2021 following advice that people under the age of 50 take Pfizer's COVID-19 vaccine rather than AstraZeneca's shot. Read more »

AstraZeneca says it had positive meeting with EU over vaccine row

Francesca Landini, Reuters
Posted at Apr 12 06:56 AM

AstraZeneca had a positive meeting with the European Commission last week, the Anglo-Swedish company said after an Italian newspaper said the group had not replied to an EU letter of complaint over COVID-19 vaccines within a 20-day deadline. Read more »

S.Korea to resume wider use of AstraZeneca COVID vaccine, exclude people under 30

Josh Smith, Reuters
Posted at Apr 11 03:29 PM

South Korean authorities said on Sunday they will move ahead with a coronavirus vaccination drive this week, after deciding to continue using AstraZeneca PLC's vaccine for all eligible people 30 years old or over. Read more »